Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, November 25, 2009, 12:42pm SGT - The Singapore stock market closes in 4 hours and 18 minutes.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
Array BioPharma, Inc. (ARRY)
At 5:00AM SGT:
1.93 USD
0.01 (0.52%)
MORE ON ARRY
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Array BioPharma Inc.
(NGM:ARRY) Delayed quote data
After Hours:
1.93
0.00 (0.02%)
as of 5:16am SGT on 11/25/09
Last Trade:
1.93 USD
Trade Time:
5:00AM SGT
Change:
0.01 (0.52%)
Prev Close:
1.94
Open:
1.93
Bid:
1.01
x 100
Ask:
2.83
x 100
1y Target Est:
5.66
Day's Range:
1.90 - 1.96
52wk Range:
1.68 - 4.68
Volume:
111,905
Avg Vol
(3m)
:
399,459
Market Cap:
95.17M
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-2.48
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Use Y! Toolbar to track stocks
Add ARRY to Portfolio
Download Data
HEADLINES
Array BioPharma to Present at the Piper Jaffray Healthcare Conference
Business Wire
(Tue 1:59am)
ARRAY BIOPHARMA INC Financials
EDGAR Online Financials
(Fri, Nov 6)
HEADLINE STOCKS-U.S. small/midcap stocks on the move on Nov 5
at Reuters
(Fri, Nov 6)
Array Biopharma upgraded by UBS
Briefing.com
(Thu, Nov 5)
ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal
EDGAR Online
(Wed, Nov 4)
Array BioPharma Inc. F1Q10 (Quarter Ended June 30, 2010) Earnings Call Transcript
at Seeking Alpha
(Wed, Nov 4)
Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today
CCBN
(Tue, Nov 3)
ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online
(Tue, Nov 3)
Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2010
Business Wire
(Tue, Nov 3)
Q1 2010 Array BioPharma Inc. Earnings Release - After Market Close
CCBN
(Mon, Nov 2)
More Headlines for ARRY...
ANALYST
EPS Est (next year)
(Jun-10)
:
-2.00
EPS Est (in 2 years)
(Jun-11)
:
-1.79
Avg Rec (current)*:
2.1
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer, inflammatory, and metabolic diseases in North America, Europe, and Asia Pacific.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices